{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/133042781"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "For example, a sample, such as blood, cerebrospinal fluid or tissue, may be taken from a patient and evaluated with the tyramine compounds of the present invention and a binding assay, as described herein, to identify the presence of neurotoxins in the patient or to identify patients who may suffer from an immune-mediated neurodegenerative disease or disorder." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "google.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/160767066"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/133042781"] } } }
